Introduction

ASCLD Train the Director – Toxicology: Instrumentation, Methodology, and Workflows

ASCLD Train the Director – Toxicology: Instrumentation, Methodology, and Workflows

← Back to Series

This webinar originally occurred on February 6, 2020
Duration: 1.5 hours

Overview

Legacy workflows in toxicology generally involve a drug class screen followed by a gas chromatography/mass spectroscopy (GC/MS) and liquid chromatography mass spectroscopy (LC/MS-MS) confirmation analysis. Additional techniques could also be used in workflows, but their applications were focused on specific drugs. In general, analyses were serial, limited, and often required multiple methods depending on the number of drug classes in the samples. Results required lengthy and costly workflows, especially when toxicologists were working with complicated samples.

Advances in chromatography and mass spectroscopy instrumentation have created opportunities to reduce extractions, increase simultaneous and parallel analyses, reduce sample handling and cost, analyze a broader range of drug classes, and quantitate more routinely. The introduction of technologies like quadrupole time-of flight (QTOF) and high-resolution mass spectroscopy can significantly improve the operations of a toxicology laboratory

Quantitations and broad spectrum analyses have always been a requirement of post-mortem (PM) toxicology. However, driving-under-the-influence of drugs (DUID) analysis is now approaching the complexity and breadth of PM toxicology. Laboratories are required to go well beyond DUI/alcohol impairment information to a multitude of drug classes, including anti-anxiety medications, sedatives, volatiles, pain medications, fentanyl, cannabinoids, barbiturates, and others. Traditional drugs of abuse are also included in the requested analyses. In addition to this range of drugs, quantitative information (including multiple replicates if possible) is extremely valuable for stakeholders.

Detailed Learning Objectives


This presentation discussed advances and the logistics of transitioning from the legacy workflows of multiple serial analyses to parallel LC/MS/MS and QTOF methods. Topics included:

  1. Budgeting and purchasing appropriate equipment
  2. Available grants, state and federal partners, and funding sources
  3. Method transitions including extractions, batching, and results interpretation
  4. Data systems integration and processing of high volumes of information
  5. Personnel and validation
  6. Trends in the processing of PM and DUID toxicology casework
  7. Current and future OSAC recommendations with laboratory methods and decisions
  8. Challenges with resources, reporting requirements, and LIMS integration

Presenters

  • Bruce Houlihan | Director of the Orange County Crime Laboratory in southern California
  • Dan Anderson | Forensic Toxicologist with the Colorado Bureau of Investigation

Funding for this Forensic Technology Center of Excellence webinar has been provided by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.

The opinions, findings, and conclusions or recommendations expressed in this webinar are those of the presenter(s) and do not necessarily reflect those of the U.S. Department of Justice.

Contact us at ForensicCOE@rti.org with any questions and subscribe to our newsletter for notifications.


Related Content

Success Story: NIJ and The Virginia Department of Forensic Science Advancing Drug Analysis in Forensic Toxicology for Enhanced Judicial Outcomes

National Institute of Justice and the Virginia Department of Forensic Science Date July 2024 Overview The Virginia Department of Forensic Science (DFS) developed two novel analytical methods using liquid chromatography tandem mass spectrometry (LC-MS/MS) to improve efficiency, detection, and productivity…

Graphic Description – Medicolegal Death Investigation Frequently Used Data Elements for Toxicology and Seized Drugs

Date February 2024 Overview The National Institute of Justice (NIJ)-in partnership with its Forensic Technology Center of Excellence (FTCOE) at RTI International and the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC)-convened a virtual Medicolegal Death…

White Paper – Forensic Community Drug Database Conceptualization

Date February 2024 Overview The National Institute of Justice (NIJ)-in partnership with its Forensic Technology Center of Excellence (FTCOE) at RTI International and the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC)-convened a virtual Medicolegal Death…